United States Rivaroxaban Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Rivaroxaban

Revenue, means the sales value of Rivaroxaban

This report studies sales (consumption) of Rivaroxaban in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Rivaroxaban in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Rivaroxaban Market Report 2016

Table of Contents
United States Rivaroxaban Market Report 2016
1 Rivaroxaban Overview
1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Rivaroxaban
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Rivaroxaban (2011-2021)
1.4.1 United States Rivaroxaban Sales and Growth Rate (2011-2021)
1.4.2 United States Rivaroxaban Revenue and Growth Rate (2011-2021)
2 United States Rivaroxaban Competition by Manufacturers
2.1 United States Rivaroxaban Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Rivaroxaban Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Rivaroxaban Average Price by Manufactures (2015 and 2016)
2.4 Rivaroxaban Market Competitive Situation and Trends
2.4.1 Rivaroxaban Market Concentration Rate
2.4.2 Rivaroxaban Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Rivaroxaban Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Rivaroxaban Sales and Market Share by Type (2011-2016)
3.2 United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
3.3 United States Rivaroxaban Price by Type (2011-2016)
3.4 United States Rivaroxaban Sales Growth Rate by Type (2011-2016)
4 United States Rivaroxaban Sales (Volume) by Application (2011-2016)
4.1 United States Rivaroxaban Sales and Market Share by Application (2011-2016)
4.2 United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Rivaroxaban Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Rivaroxaban Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Rivaroxaban Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Rivaroxaban Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Rivaroxaban Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Rivaroxaban Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Rivaroxaban Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Rivaroxaban Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Rivaroxaban Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Rivaroxaban Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Rivaroxaban Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Rivaroxaban Manufacturing Cost Analysis
6.1 Rivaroxaban Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Rivaroxaban
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Rivaroxaban Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Rivaroxaban Market Forecast (2016-2021)
10.1 United States Rivaroxaban Sales, Revenue Forecast (2016-2021)
10.2 United States Rivaroxaban Sales Forecast by Type (2016-2021)
10.3 United States Rivaroxaban Sales Forecast by Application (2016-2021)
10.4 Rivaroxaban Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Rivaroxaban
Table Classification of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Type in 2015
Table Application of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Application in 2015
Figure United States Rivaroxaban Sales and Growth Rate (2011-2021)
Figure United States Rivaroxaban Revenue and Growth Rate (2011-2021)
Table United States Rivaroxaban Sales of Key Manufacturers (2015 and 2016)
Table United States Rivaroxaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rivaroxaban Sales Share by Manufacturers
Figure 2016 Rivaroxaban Sales Share by Manufacturers
Table United States Rivaroxaban Revenue by Manufacturers (2015 and 2016)
Table United States Rivaroxaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Rivaroxaban Revenue Share by Manufacturers
Table 2016 United States Rivaroxaban Revenue Share by Manufacturers
Table United States Market Rivaroxaban Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Rivaroxaban Average Price of Key Manufacturers in 2015
Figure Rivaroxaban Market Share of Top 3 Manufacturers
Figure Rivaroxaban Market Share of Top 5 Manufacturers
Table United States Rivaroxaban Sales by Type (2011-2016)
Table United States Rivaroxaban Sales Share by Type (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Type in 2015
Table United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
Table United States Rivaroxaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Type (2011-2016)
Table United States Rivaroxaban Price by Type (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Type (2011-2016)
Table United States Rivaroxaban Sales by Application (2011-2016)
Table United States Rivaroxaban Sales Market Share by Application (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Application in 2015
Table United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Rivaroxaban Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Rivaroxaban Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Rivaroxaban Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure United States Rivaroxaban Production and Growth Rate Forecast (2016-2021)
Figure United States Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Table United States Rivaroxaban Production Forecast by Type (2016-2021)
Table United States Rivaroxaban Consumption Forecast by Application (2016-2021)
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Embolization Particle Market 2018 Forecast to 2023
    Published: 15-Feb-2018        Price: US 4880 Onwards        Pages: 105
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. Scope of the Report: This report focuses on the Embolization Particle in Global market, especially in ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Eye Anatomical Model Market 2018 Forecast to 2023
    Published: 15-Feb-2018        Price: US 4880 Onwards        Pages: 103
    Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models. Scope of the Report: This report focuses on the Eye Anatomical Model in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Flush Syringe Market 2018 Forecast to 2023
    Published: 15-Feb-2018        Price: US 4880 Onwards        Pages: 107
    This report studies the IV Flush Syringe market. Health care professionals use IV flush syringes to clear out patients' catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 2016 after the devices spread a bacterial infection. Patients became sick and some died. How the syringes became contaminated with the bacteria Burkholderia cepacia remains unknown. Scope ......
  • Global Bioprocess Technology Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 109
    This report studies the global Bioprocess Technology market, analyzes and researches the Bioprocess Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Thermo Fisher Scientific - Sartorius Aktiengesellschaft - Repligen Corporation - General Electric Company - Corning Incorporated - Eppendorf AG - Lonza Group - Abbott Laborato......
  • Global Enteric Disease Testing Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 94
    This report studies the global Enteric Disease Testing market, analyzes and researches the Enteric Disease Testing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Trinity Biotech - Biomerica - Bio-Rad Laboratories - Alere - Biomerieux - Meridian Bioscience - CorisBioconcept SPRL - Quest Diagnostics Incorporated - Cepheid......
  • Global Missile Defence System Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 95
    This report studies the global Missile Defence System market, analyzes and researches the Missile Defence System development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BAE - General Dynamics - Lockheed Martin - Northrop Grumman - Raytheon - Finmeccanica - MBDA - Rafael Advanced Defense Systems - Saab AB - Thales ......
  • Global Paracetamol Consumption Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 104
    This report studies the global Paracetamol Consumption market, analyzes and researches the Paracetamol Consumption development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - AriZona Beverages - Coca-Cola - Nestle - Knudsen & Sons - PepsiCo - S. Martinelli & Company - Ocean Spray - Campbell Soup Company - Mayador - White Rock Beve......
  • Global Health Intelligent Virtual Assistant Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 95
    This report studies the global Health Intelligent Virtual Assistant market, analyzes and researches the Health Intelligent Virtual Assistant development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Next IT Corporation - Microsoft Corporation - Nuance Communications - eGain Corporation - True Image Interactive - CodeBaby Corporation - Kognito ......
  • Global Endovenous Laser Treatment Market Size, Status and Forecast 2025
    Published: 14-Feb-2018        Price: US 3300 Onwards        Pages: 93
    This report studies the global Endovenous Laser Treatment market, analyzes and researches the Endovenous Laser Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - AngioDynamics - Syneron Medical - Dornier Medtech - Alma Lasers - Alna-Medicalsystem - LSO Medical - WONTECH - intros Medical Laser - Energist ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs